Cargando…
Trajectories of hospitalisation for patients infected with SARS-CoV-2 variant B.1.1.7 in Norway, December 2020 – April 2021
Autores principales: | Whittaker, Robert, Kristofferson, Anja Bråthen, Seppälä, Elina, Valcarcel Salamanca, Beatriz, Veneti, Lamprini, Storm, Margrethe Larsdatter, Bøås, Håkon, Aasand, Nina, Naseer, Umaer, Bragstad, Karoline, Kvåle, Reidar, Golestani, Karan, Feruglio, Siri, Vold, Line, Nygård, Karin, Buanes, Eirik Alnes |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The British Infection Association. Published by Elsevier Ltd.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8316639/ https://www.ncbi.nlm.nih.gov/pubmed/34329674 http://dx.doi.org/10.1016/j.jinf.2021.07.025 |
Ejemplares similares
-
Increased risk of hospitalisation and intensive care admission associated with reported cases of SARS-CoV-2 variants B.1.1.7 and B.1.351 in Norway, December 2020 –May 2021
por: Veneti, Lamprini, et al.
Publicado: (2021) -
No difference in risk of hospitalization between reported cases of the SARS-CoV-2 Delta variant and Alpha variant in Norway
por: Veneti, Lamprini, et al.
Publicado: (2022) -
Reduced risk of hospitalisation among reported COVID-19 cases infected with the SARS-CoV-2 Omicron BA.1 variant compared with the Delta variant, Norway, December 2021 to January 2022
por: Veneti, Lamprini, et al.
Publicado: (2022) -
Length of hospital stay and risk of intensive care admission and in-hospital death among COVID-19 patients in Norway: a register-based cohort study comparing patients fully vaccinated with an mRNA vaccine to unvaccinated patients
por: Whittaker, Robert, et al.
Publicado: (2022) -
Implementation of multiplex PCR diagnostics for gastrointestinal pathogens linked to increase of notified Shiga toxin-producing Escherichia coli cases in Norway, 2007–2017
por: Jenssen, Gaute Reier, et al.
Publicado: (2019)